Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Anethum graveolens essential oil, commonly known as dill seed oil, is a natural phytochemical complex extracted from the seeds of the dill plant via steam or hydrodistillation. Its primary bioactive constituents include carvone, d-limonene, and dillapiole. The oil exhibits a range of pharmacological activities, including antimicrobial, antioxidant, anti-inflammatory, and antispasmodic effects. In research settings, it has demonstrated cytotoxic and antiproliferative properties against various cancer cell lines, such as HepG2 (human hepatocellular carcinoma), by inducing G2/M and pre-G1 cell cycle arrest and promoting apoptosis. Clinically, it has been investigated for the management of gastrointestinal symptoms like flatulence and abdominal pain, particularly in post-surgical contexts.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on anethum graveolens essential oil.